Michael Recht
InvestorChair, P2C Scientific Advisory Group and Chief Medical and Scientific Advisor at Pathway to Cures
Charlestown, Rhode Island, United States
Find your path to Michael
174 people in our graph share verified history with Michael β schools, employers, funds. One of them is your warm intro.
DougunlockedMichael: together at University of Wisconsin-Madison (1991β1992)
Γ5Michael: together at Yale School of Medicine
Γ4Michael: together at University of Wisconsin-Madison
Γ2Michael: together at Oregon Health & Science University
About
A pediatric hematology leader and Professor of Clinical Pediatrics at Yale University School of Medicine, Recht serves as P2C's Chief Medical and Scientific Advisor. He previously was Chief Science Officer at ATHN and directed hemophilia centers at OHSU.
Experience
- Pathway to CuresChief Medical and Scientific Advisorcurrent2026 β present
- Pathway to CuresChair, Scientific Advisory Groupcurrent2023 β present
- Yale University School of MedicineProfessor of Pediatricscurrent2022 β presentNew Haven, Connecticut, United States
- National Bleeding Disorders FoundationChief Medical and Scientific Officer2023 β 2025New York, New York, United States
- American Thrombosis and Hemostasis Network (ATHN)Chief Science Officer2019 β 2023
- Oregon Health & Science UniversityProfessor of Pediatrics and Medicine, The Hemophilia Center2007 β 2022
- Phoenix Children's HospitalDirector, The Hemophilia Center1998 β 2007Phoenix, Arizona Area
Skills & more
HealthcareHospitalsClinical ResearchHealthcare ManagementConsensus Building
From Michael's professional profile.
Colleagues at Pathway to Cures
Amy L. Dunn
Chair, Medical and Scientific Advisory Council (MASAC) for NBDF at Pathway to Cures
Beth Whitehouse
NBDF Senior Vice President for Advancement at Pathway to Cures
Brian Andrew
Investment Committee Chair at Pathway to Cures
Christine Brennan
Investment Committee Member at Pathway to Cures
Geeta Vemuri
Managing Partner, Founder at Agent Capital
Gilbert C. White
P2C Board Vice Chair & Secretary at Pathway to Cures
Gilbert C. White, II
P2C Board Vice Chair & Secretary at Pathway to Cures
Glenn Pierce
Scientific Advisory Group Co-Chair at Pathway to Cures
Frequently asked questions
- Who is Michael Recht?
- A pediatric hematology leader and Professor of Clinical Pediatrics at Yale University School of Medicine, Recht serves as P2C's Chief Medical and Scientific Advisor. He previously was Chief Science Officer at ATHN and directed hemophilia centers at OHSU.
- Where does Michael Recht work?
- Michael Recht is Chair, P2C Scientific Advisory Group and Chief Medical and Scientific Advisor at Pathway to Cures.
- Where did Michael Recht go to school?
- Michael Recht studied at The Johns Hopkins University (Certificate in Artificial Intelligence in Healthcare); Oregon Health & Science University (Master of Business Administration (MBA), Health/Health Care Administration/Management); Yale School of Medicine (Fellowship, Pediatric Hematology-Oncology).
Same school
Also attended The Johns Hopkins University474
Dave JohnsonCo-founder & CEO of Dash BioNicole GaudelliEntrepreneur in Residence at GV (Google Ventures)Wes NicholsPartner at March Capital PartnersDemi ObayomiPrincipal at Sapphire VenturesJun JeonInvestor at Khosla VenturesNicole FraenkelInvestor at Khosla Ventures
+ 468 more
Also attended Oregon Health & Science University17
Janelle GoulardPartner at Pangaea Ventures Us Inc.Sherwin KuoInvestor at FusionKid ParchariyanonFounder and Managing Partner at SeaX VenturesBrian MillsVice President at Pivotal Life SciencesDr. Balvant AroraAdvisor at VDOSHLawrence HamPartner at Anderson Angels
+ 11 more
Also attended Yale School of Medicine59
Lars PedersenPartner, Chief Financial Officer at Redpoint VenturesAlexi Nazem, MDGeneral Partner at AlleyCorpElias QuijanoPrincipal at Northpond VenturesJeffrey LowPartner at Averin CapitalBridget Martell MA, MDSenior Biopharmaceutical Advisor at Two Bear CapitalAlley (Welsh) OlshanskyAdvisor at Casdin Capital
+ 53 more
Also attended University of Wisconsin-Madison504
Zhenyu TangInvestment Director at Intel CapitalDougAdvisor at Clear VenturesDan RuchPartner at Rho VenturesJoe HayesInvestor at LightbankGeorge RobertsInvestor at OpenView Venture PartnersBret L. BostwickMD, FAAP, FACMG, Venture Advisor at Breyer Capital
+ 498 more
Shared employers
Also worked at Yale University School of Medicine72
Karthik ArdhanareeswaranInvestor at GV (Google Ventures)Brittany de KouchkovskyDirector, University Relations at Osage University PartnersDavid Rosenthal, MDVenture Partner at AlleyCorpAlley (Welsh) OlshanskyAdvisor at Casdin CapitalSophie RobinsonSenior Associate at Cure VenturesJonathan GertlerManaging Director at Bioventures Investors
+ 66 more
Also worked at Oregon Health & Science University28
Jessica A. Zeaske, PhD, MBAManaging Partner, Strategic Investment at Echo Health VenturesKevin GroveVenture Partner at Versant VenturesRay CostantiniVenture Partner at Suncoast VenturesShereef ElnahalObvious Champion at Obvious VenturesKristen WongVenture Partner at Altitude Ventures Management, LlcBrian MillsVice President at Pivotal Life Sciences
+ 22 more











































